Carol Midgley

5.7k total citations · 4 hit papers
32 papers, 4.8k citations indexed

About

Carol Midgley is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Carol Midgley has authored 32 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Oncology and 10 papers in Biotechnology. Recurrent topics in Carol Midgley's work include Cancer-related Molecular Pathways (21 papers), Cancer Research and Treatments (10 papers) and Ubiquitin and proteasome pathways (5 papers). Carol Midgley is often cited by papers focused on Cancer-related Molecular Pathways (21 papers), Cancer Research and Treatments (10 papers) and Ubiquitin and proteasome pathways (5 papers). Carol Midgley collaborates with scholars based in United Kingdom, Czechia and United States. Carol Midgley's co-authors include David P. Lane, Ted R. Hupp, David W. Meek, Bořivoj Vojtěšek, Sonia Laı́n, Jiří Bártek, Joana Desterro, Ronald T. Hay, Manuel S. Rodríguez and H.R. Hoogenboom and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Carol Midgley

30 papers receiving 4.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of the specific DNA binding function of p53

1992 800 citations Ted R. Hupp, David W. Meek et al. Cell profile →
SUMO-1 modification activates the transcriptional response of p53

1999 541 citations Manuel S. Rodríguez, Joana Desterro et al. The EMBO Journal profile →
An immunochemical analysis of the human nuclear phosphoprotein p53

1992 503 citations Bořivoj Vojtěšek, Jiří Bártek et al. Journal of Immunological Methods profile →
Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.

1994 468 citations Ahuva Nissim, H.R. Hoogenboom et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol Midgley United Kingdom	27	3.5k	3.0k	824	597	461	32	4.8k
Beverly Plunkett United States	18	3.8k 1.1×	3.7k 1.3×	1.0k 1.2×	1.0k 1.7×	203 0.4×	22	5.9k
William Walsh United States	10	3.3k 0.9×	3.2k 1.1×	877 1.1×	906 1.5×	188 0.4×	41	4.6k
Claude Caron de Fromentel France	27	2.3k 0.7×	2.5k 0.8×	578 0.7×	924 1.5×	138 0.3×	49	3.8k
Sumitra Deb United States	32	2.2k 0.6×	2.3k 0.8×	463 0.6×	471 0.8×	100 0.2×	79	3.5k
Neil I. Goldstein United States	27	2.2k 0.6×	2.1k 0.7×	272 0.3×	499 0.8×	656 1.4×	64	4.3k
Dalia Resnitzky Israel	18	2.7k 0.8×	2.3k 0.8×	249 0.3×	410 0.7×	131 0.3×	21	3.8k
Masatoshi Tagawa Japan	35	2.3k 0.6×	1.7k 0.6×	431 0.5×	564 0.9×	270 0.6×	210	4.6k
Brian Elenbaas United States	17	2.8k 0.8×	2.4k 0.8×	524 0.6×	640 1.1×	61 0.1×	26	4.1k
Vincent L. Morris Canada	25	1.3k 0.4×	1.5k 0.5×	360 0.4×	833 1.4×	162 0.4×	44	3.1k
Ulrich H. Weidle Germany	48	3.9k 1.1×	2.0k 0.7×	314 0.4×	2.3k 3.9×	547 1.2×	160	6.7k

Countries citing papers authored by Carol Midgley

Since Specialization

Citations

This map shows the geographic impact of Carol Midgley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Midgley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Midgley more than expected).

Fields of papers citing papers by Carol Midgley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Midgley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Midgley. The network helps show where Carol Midgley may publish in the future.

Co-authorship network of co-authors of Carol Midgley

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Midgley. A scholar is included among the top collaborators of Carol Midgley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Midgley. Carol Midgley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chahrour, Osama, Ashraf N. Abdalla, Frankie Lam, Carol Midgley, & Shudong Wang. (2011). Synthesis and biological evaluation of benzyl styrylsulfonyl derivatives as potent anticancer mitotic inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(10). 3066–3069. 15 indexed citations

Higgins, J. William, Carol Midgley, Sandra Bell, et al.. (2010). Human ASPM participates in spindle organisation, spindle orientation and cytokinesis. BMC Cell Biology. 11(1). 85–85. 95 indexed citations

McInnes, Campbell, A. Mazumdar, Mokdad Mezna, et al.. (2006). Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nature Chemical Biology. 2(11). 608–617. 80 indexed citations

Wang, Shudong, Gavin Wood, Christopher Meades, et al.. (2004). Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(16). 4237–4240. 53 indexed citations

Midgley, Carol, et al.. (2001). Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein. Journal of Molecular Biology. 313(4). 711–731. 34 indexed citations

Burch, Lindsay, et al.. (2000). Mdm2 binding to a conformationally sensitive domain on p53 can be modulated by RNA. FEBS Letters. 472(1). 93–98. 29 indexed citations

Rodríguez, Manuel S., Joana Desterro, Sonia Laı́n, et al.. (1999). SUMO-1 modification activates the transcriptional response of p53. The EMBO Journal. 18(22). 6455–6461. 541 indexed citations breakdown →

Budhram‐Mahadeo, Vishwanie, Peter J. Morris, Martin Smith, et al.. (1999). p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor. Journal of Biological Chemistry. 274(21). 15237–15244. 121 indexed citations

Hansen, Silke, David P. Lane, & Carol Midgley. (1998). The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability 1 1Edited by J. Karn. Journal of Molecular Biology. 275(4). 575–588. 35 indexed citations

10.

Midgley, Carol & David P. Lane. (1997). p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene. 15(10). 1179–1189. 270 indexed citations

11.

Midgley, Carol, Susan M. White, Rachel Howitt, et al.. (1997). APC EXPRESSION IN NORMAL HUMAN TISSUES. The Journal of Pathology. 181(4). 426–433. 5 indexed citations

12.

Hansen, Silke, Carol Midgley, David P. Lane, et al.. (1996). Modification of Two Distinct COOH-terminal Domains Is Required for Murine p53 Activation by Bacterial Hsp70. Journal of Biological Chemistry. 271(48). 30922–30928. 25 indexed citations

13.

Lane, David P., Carol Midgley, Ted R. Hupp, et al.. (1995). On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damage. Philosophical Transactions of the Royal Society B Biological Sciences. 347(1319). 83–87. 40 indexed citations

14.

Cox, Lynne S., Ted R. Hupp, Carol Midgley, & David P. Lane. (1995). A direct effect of activated human p53 on nuclear DNA replication.. The EMBO Journal. 14(9). 2099–2105. 71 indexed citations

15.

Nissim, Ahuva, H.R. Hoogenboom, Ian M. Tomlinson, et al.. (1994). Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.. The EMBO Journal. 13(3). 692–698. 468 indexed citations breakdown →

16.

Hupp, Ted R., David W. Meek, Carol Midgley, & David P. Lane. (1993). Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Research. 21(14). 3167–3174. 167 indexed citations

17.

Lane, David P., Carol Midgley, & Ted R. Hupp. (1993). Tumour suppressor genes and molecular chaperones. Philosophical Transactions of the Royal Society B Biological Sciences. 339(1289). 369–373. 31 indexed citations

18.

Vojtěšek, Bořivoj, Jiří Bártek, Carol Midgley, & David P. Lane. (1992). An immunochemical analysis of the human nuclear phosphoprotein p53. Journal of Immunological Methods. 151(1-2). 237–244. 503 indexed citations breakdown →

19.

Hupp, Ted R., David W. Meek, Carol Midgley, & David P. Lane. (1992). Regulation of the specific DNA binding function of p53. Cell. 71(5). 875–886. 800 indexed citations breakdown →

20.

Bártek, Jiří, Bořivoj Vojtěšek, Z Stasková, et al.. (1991). p53 Protein alterations in human testicular cancer including pre‐invasive intratubular germ‐cell neoplasia. International Journal of Cancer. 49(2). 196–202. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact